Table 3 Clinical outcomes between early group and control group before and after sIPTW.
Outcome | Early group | Control group | P |
---|---|---|---|
Pre-adjusted | |||
Death, n (%) | 19 (32.76) | 39 (52.70) | 0.022 |
ICU stay, days | 19.90 ± 6.55 | 21.12 ± 7.93 | 0.344 |
Invasive MV, days | 10.66 ± 5.49 | 14.38 ± 4.98 | 0.002 |
Vasoactive agent, days | 4.12 ± 2.08 | 7.86 ± 2.64 | < 0.001 |
sIPTW-adjusted | |||
Death, n (%) | 13 (27.66) | 47 (63.51) | < 0.001 |
ICU stay, days | 19.08 ± 5.42 | 21.67 ± 8.11 | 0.133 |
Invasive MV, days | 9.95 ± 5.42 | 12.24 ± 4.77 | 0.003 |
Vasoactive agent, days | 4.16 ± 1.97 | 8.11 ± 2.70 | < 0.001 |